Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Validity of a Novel Diabetes Diagnostic Device and Its Feasibility as Metabolic Syndrome Diagnostic One. [TREARS STUDIES II]

NCT06932601 is registered in ClinicalTrials.gov with Trears as lead sponsor.

NCT NCT06932601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06932601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Validity of a Novel Diabetes Diagnostic Device and Its Feasibility as Metabolic Syndrome Diagnostic One. [TREARS STUDIES II]
Lead sponsor
Trears
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
July 1, 2027
Enrollment
258 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypertension, metabolic syndrome, obesity and obesity-related medical conditions